# Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)

> **NCT07161479** · NA · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 160 (estimated)

## Conditions studied

- Gastric Adenoma
- Stomach Neoplasms
- Precancerous Conditions
- Dysplasia Stomach

## Interventions

- **PROCEDURE:** Argon Plasma Coagulation (APC)
- **PROCEDURE:** Endoscopic Mucosal Resection (EMR)

## Key facts

- **NCT ID:** NCT07161479
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-20
- **Primary completion:** 2026-08
- **Final completion:** 2026-10
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07161479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07161479, "Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07161479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*